FBXL5 and pulmonary fibrosis: Furthermore, our study showed that EP4 receptor activation considerably increased FBXL5 levels and effectively blocked the IREB2-MFRN2 axis, thereby reducing AECII mitochondrial iron deposition and attenuating fibrosis severity in BLM-induced pulmonary fibrosis mice.